In a groundbreaking clinical trial, a patient with a rare form of cancer is finding hope through TCR-T Cell Therapy. This innovative immunotherapy approach, conducted through a collaboration between Memorial Cancer Institute and Moffett Cancer Center, involves modifying the patient’s T-cells to target specific proteins in cancer cells. By harnessing the power of the body’s immune system, this personalized treatment aims to eradicate diseased cells and pave the way for future advancements in cancer care. Stay tuned for updates on this promising research.
Read more about this — here
